Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection

Nature Medicine

Volumn 8, Issue 4, 2002, Pages 373-378

  Kopf, Manfred ^a,b   Abel, Brian ^a,b   Gallimore, Awen ^c   Carroll, Michael ^d   Bachmann, Martin F ^e  

^a ETH ZURICH   (Switzerland)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR CR2; GAMMA INTERFERON; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HELPER CELL; IMMUNE SYSTEM; INFECTION CONTROL; INFLUENZA; LUNG INFECTION; LYMPH NODE; MOUSE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS TITRATION;

ANIMALS; ANTIBODIES, VIRAL; CELL MOVEMENT; COMPLEMENT C3; IMMUNOGLOBULIN G; INTERFERON TYPE II; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

ANIMALIA; INFLUENZA VIRUS;

EID: 0036104834     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0402-373     Document Type: Article

References (43)

1. Linkages of innate and adaptive immunity
2. Complement receptors, adhesion, and phagocytosis
3. The membrane attack complex of complement
4. Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells
5. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes
6. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes
7. Dual antigen recognition by B cells
8. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
9. Role of complement in induction of antibody production In vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
10. Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
11. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
12. Antibody response to a T-dependent antigen requires B cell expression of complement receptors
13. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
14. Complement dependence of localisation of aggregated IgG in germinal centres
15. Follicular dendritic cells as accessory cells
16. Studies of group B streptococcal infection in mice deficient in complement component C 3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
17. Endotoxin shock in antibody-deficient mice: Unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide
18. Complement deficiency and disease
19. Neutralization of sensitized virus by the fourth component of complement
20. Complement components required for virus neutralization by early immunoglobulin antibody
21. Antibody-complement interactions with purified lymphocytic choriomeningitis virus
22. Humoral response to herpes simplex virus is complement-dependent
23. Protective T cell-independent antiviral antibody responses are dependent on complement
24. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice
25. Role of the B-cell response in recovery of mice from primary influenza virus infection
26. + T-cell mechanisms in the control of respiratory virus infections
27. Regulation of the B cell response to T-dependent antigens by classical pathway complement
28. In vivo versus In vitro assays for assessment of T-and B-cell function
29. Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen
30. Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections
31. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response
32. Complement facilitates early prion pathogenesis
33. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie
34. Human T cells express the C5a receptor and are chemoattracted to C5a
35. Attenuation of experimental autoimmune demyelination in complement-deficient mice
36. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease
37. The C5a chemoattractant receptor mediates mucosal defence to infection
38. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma
39. Protective effects of C5a blockade in sepsis
40. A role for the C3a anaphylatoxin receptor in the effector phase of asthma
41. Influenza virus: A novel method to assess viral and neutralizing antibody titers in vitro
42. The antigen dose determines T helper subset development by regulation of CD40 ligand
43. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection